In this engaging dialogue, 2 expert hepatologists discuss strategies for maintaining and even improving care of patients with HCC or liver transplantation despite the challenges posed by the COVID-19 pandemic.
In this episode, Graham R. Foster, FRCP, PhD, and Paul Y. Kwo, MD, share lessons learned in the management of HCC and liver transplantation the COVID-19 era, including:
• Global impact of HCC and strategies for maintaining HCC care in the COVID-19 era
• Characteristics of liver transplant recipients in the COVID-19 era
• Impact of COVID-19 pandemic period on liver transplant outcomes
• Impact of liver transplant status on COVID-19 outcomes
• Strategies for providing streamlined care for patients with liver cancer or liver transplantation in the COVID-19 era
Presenters:
Graham R. Foster, FRCP, PhD
Professor of Hepatology
The Liver Unit
Consultant Hepatologist
Queen Mary University of London
London, United Kingdom
Paul Y. Kwo, MD
Professor of Medicine
Director of Hepatology
Stanford University School of Medicine
Palo Alto, California
Follow along with the slides at:
https://bit.ly/3HQ6dZ5
Link to full program:
https://bit.ly/3Bgyd5I